PDS Biotechnology Corp Current Income Tax Expense (Benefit)
PDS Biotechnology Corp (PDSB) reported Current Income Tax Expense (Benefit) of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-08-13
- PDS Biotechnology Corp current income tax expense (benefit) for the quarter ending 2026-06-30 was $0.00.
- PDS Biotechnology Corp current income tax expense (benefit) for the quarter ending 2026-03-31 was $0.00.
- PDS Biotechnology Corp current income tax expense (benefit) for the quarter ending 2025-12-31 was -$1.17M.
- PDS Biotechnology Corp current income tax expense (benefit) for the quarter ending 2025-09-30 was $0.00.
- PDS Biotechnology Corp current income tax expense (benefit) for fiscal 2025 was -$1.17M.
- PDS Biotechnology Corp current income tax expense (benefit) for fiscal 2024 was -$869.17K.
| Period end | Current Income Tax Expense (Benefit) 3 month | Current Income Tax Expense (Benefit) 6 month | Current Income Tax Expense (Benefit) 9 month | Current Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | -$1.17M derived: sum of 3 quarters · filed 2026-08-13 | -$1.17M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | -$1.17M derived: sum of 2 quarters · filed 2026-05-14 | -$1.17M derived: sum of 3 quarters · filed 2026-05-14 | -$1.17M derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | -$1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$1.17M derived: sum of 2 quarters · filed 2026-03-30 | -$1.17M derived: sum of 3 quarters · filed 2026-03-30 | -$1.17M 10-K · filed 2026-03-30 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | -$869.17K derived: sum of 4 quarters · filed 2026-03-30 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $0.00 10-Q · filed 2025-08-13 | -$869.17K derived: sum of 3 quarters · filed 2026-03-30 | -$869.17K derived: sum of 4 quarters · filed 2026-03-30 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 | -$869.17K derived: sum of 2 quarters · filed 2026-03-30 | -$869.17K derived: sum of 3 quarters · filed 2026-03-30 | -$869.17K derived: sum of 4 quarters · filed 2026-03-30 |
| 2024-12-31 | -$869.17K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$869.17K derived: sum of 2 quarters · filed 2026-03-30 | -$869.17K derived: sum of 3 quarters · filed 2026-03-30 | -$869.17K 10-K · filed 2026-03-30 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | ||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-15 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | ||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 | |||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | ||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-11 | |||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-13 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $0.00 derived: sum of 2 quarters · filed 2020-11-13 | $0.00 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $0.00 10-Q · filed 2020-08-13 | ||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-13 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | ||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |